TY  - JOUR
AU  - Polo, Rosa
AU  - García-Albéniz, Xabier
AU  - Terán, Carolina
AU  - Morales, Miguel
AU  - Rial-Crestelo, David
AU  - Garcinuño, M Angeles
AU  - García Del Toro, Miguel
AU  - Hita, César
AU  - Gómez-Sirvent, Juan Luis
AU  - Buzón, Luis
AU  - Díaz de Santiago, Alberto
AU  - Arellano, Jose Pérez
AU  - Sanz, Jesus
AU  - Bachiller, Pablo
AU  - Alfaro, Elisa Martínez
AU  - Díaz-Brito, Vicente
AU  - Masiá, Mar
AU  - Hernández-Torres, Alicia
AU  - Guerra, Jose M
AU  - Santos, Jesús
AU  - Arazo, Piedad
AU  - Muñoz, Leopoldo
AU  - Arribas, Jose Ramon
AU  - Martínez de Salazar, Pablo
AU  - Moreno, Santiago
AU  - Hernán, Miguel A
AU  - Del Amo, Julia
AU  - EPICOS
PY  - 2022
DO  - 10.1016/j.cmi.2022.07.006
UR  - http://hdl.handle.net/10668/22134
T2  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
AB  - To assess the effect of hydroxychloroquine (HCQ) and Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as pre-exposure prophylaxis on COVID-19 risk. EPICOS is a double-blind, placebo-controlled randomized trial conducted in Spain, Bolivia, and...
LA  - en
KW  - COVID-19
KW  - Pre-exposure prophylaxis
KW  - Randomized clinical trial
KW  - SARS-CoV-2
KW  - Tenofovir
KW  - Humans
KW  - Tenofovir
KW  - Emtricitabine
KW  - Hydroxychloroquine
KW  - Anti-HIV Agents
KW  - HIV Infections
KW  - Pre-Exposure Prophylaxis
KW  - Adenine
KW  - Organophosphonates
KW  - Deoxycytidine
KW  - COVID-19
KW  - COVID-19 Drug Treatment
KW  - SARS-CoV-2
KW  - Health Personnel
KW  - Double-Blind Method
TI  - Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.
TY  - research article
VL  - 29
ER  -